#USA #Kessler Topaz #Radnor #Madrigal Pharmaceuticals #German Securities

Investigation of Madrigal Pharmaceuticals: A Call to Investors

On November 3, 2026, Kessler Topaz Meltzer & Check, LLP, a prominent securities litigation law firm, announced its investigation into Madrigal Pharmaceuticals, Inc. This inquiry centers on allegations of potential violations of federal securities laws related to the company’s reported safety data and efficacy results for their sole approved drug, Rezdiffra.

Background of the Investigation

The investigation was sparked by whistleblower complaints made by Madrigal's former Senior Vice President and Head of Clinical Development. According to the whistleblower, significant adverse safety findings related to liver function and unreliable efficacy data were allegedly concealed from the company’s senior leadership. The whistleblower claimed that Madrigal suppressed vital data about adverse effects, misrepresented efficacy results, and allowed a Board member to influence clinical outcome assessments without appropriate oversight.

Following the allegations, Madrigal’s stock price plummeted by over 8%, signaling investor anxiety about the company's practices and governance. This sudden decline highlights the potential financial ramifications for shareholders and calls into question the integrity of the company’s board and executive decisions.

Implications for Investors

Investors who acquired shares of Madrigal Pharmaceuticals and experienced substantial losses now face a critical juncture. Kessler Topaz urges anyone affected by the recent downturn to consider their legal options. Investors possess rights under federal securities laws and are encouraged to explore potential claims for recovery of losses incurred as a result of possible corporate misconduct.

How Investors Can Act

Those who purchased Madrigal’s securities and suffered losses should contact Kessler Topaz to discuss their rights and the potential for legal recourse. Engaging with a legal expert can provide clarity on the situation and outline the steps necessary for recovery. Remember, consulting with an attorney poses no cost or obligation, making it a viable option for those affected.

About Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP is renowned for its dedication to protecting investors and pursuing justice in securities fraud litigations. The firm has amassed significant recoveries for clients through class action lawsuits and has built a reputation as a leading plaintiff-side law firm. With accolades acknowledging its excellence in securities litigation, Kessler Topaz is committed to ensuring that investors can seek recovery without fear or financial burden.

For those wishing to discuss this issue further, legal representatives are available to provide assistance in navigating the complexities of securities law. Investors should remain vigilant and informed about their rights, particularly during turbulent times like these. The representation of an experienced attorney can be a crucial asset against potential corporate misconduct.